Browse by Audience
MEMBER

Update Your Profile
Member Spotlights
Refer a Member: IASP Champions
Join a Special Interest Group (SIG)
Find a Chapter
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Papers of the Week
Webinars and Podcasts
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Webinars & Podcasts
Curricula
Graduate Opportunities
Events

PATIENT & CAREGIVER

RELIEF News
Resources for Living with Pain
Global Alliance of Partners in Pain Advocacy (GAPPA)
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner

gy2022-1-3
I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study.

< BACK TO ARCHIVE


2023 Jan 16


Rev Esp Enferm Dig


http://www.ncbi.nlm.nih.gov/pubmed/36645081?dopt=Abstract


115

Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study.

Authors

Serologic response to COVID-19 vaccines in patients with inflammatory bowel disease: a prospective study.
Martín Arranz M D, García-Ramírez L, Martín Arranz E, Montero Vega D, Rueda García J L, Sánchez-Azofra M, Poza Cordón J, Noci Belda J, Verges Martínez-Meco T, Blanco San Miguel P, Suárez-Ferrer C
Rev Esp Enferm Dig. 2023 Jan 16; 115.
PMID: 36645081.

Abstract

response to the SARS-CoV-2 vaccine can be altered in patients with immune-mediated diseases, such as inflammatory bowel disease, and in patients under immunosuppressive treatment. The aims of this study were to evaluate the serologic response to the SARS-CoV-2 vaccine in patients with inflammatory bowel disease, to analyze the influence of immunosuppressive drugs on response, and to describe any adverse events in this population.
Read This Paper